The effect of intramuscular injections of boar pheromone 5alpha-androstenol on the hormonal regulation of the estrous cycle in hypoosmatic gilts.
Until 1999 it was accepted that pheromones act exclusively by stimulating the dendritic receptors present in olfactory epithelium. Cycling gilts with an experimentally-disrupted neural olfactory pathway were used to test the hypothesis that boar pheromone 5alpha-androstenol may affect the secretion of hormones involved in the regulation of the estrous cycle by the humoral pathway. On day 12 of the estrous cycle the nasal cavity of gilts (n=15) was irrigated with zink sulfate solution. From day 16 to 20, the experimental group (n=10) was injected intramuscularly with 5alpha-androstenol (20 microg) twice a day. Blood samples were collected from the jugular vein at 4 h intervals on days 17-21 to estimate plasma concentration of LH, oxytocin, estradiol-17beta, testosterone and progesterone. The experimental group displayed a significantly lower mean concentration of LH than the control animals (P<0.0001). The decrease in concentration of LH was accompanied by the reduction of oxytocin (P<0.001), estradiol-17beta (P<0.001) and testosterone (P<0.01) secretion. These results demonstrated that 5alpha-androstenol influenced hormonal regulation by humoral pathway and might be considered to be the priming pheromone in gilts.
Stefańczyk-Krzymowska
S
S
Department of Local Physiological Regulations, Institute of Animal Reproduction and Food Research of the Polish Academy of Sciences, 10-740 Olsztyn, Poland. skrzym@pan.olsztyn.pl
Wasowska
B
B
Skipor
J
J
D000737:Androstenols / Q000008:administration & dosage / Q000494:pharmacology*; D000818:Animals; D004958:Estradiol / Q000097:blood; D030762:Estrous Cycle / Q000097:blood / Q000187:drug effects* / Q000502:physiology; D004973:Estrus Synchronization; D005260:Female; D007273:Injections, Intramuscular / Q000662:veterinary; D007986:Luteinizing Hormone / Q000097:blood; D009297:Nasal Mucosa; D010121:Oxytocin / Q000097:blood; D010675:Pheromones / Q000008:administration & dosage / Q000494:pharmacology*; D011374:Progesterone / Q000097:blood; D013552:Swine / Q000502:physiology*; D013739:Testosterone / Q000097:blood; D016896:Treatment Outcome
D000737:Androstenols; D010675:Pheromones; D013739:Testosterone; D011374:Progesterone; D004958:Estradiol; D010121:Oxytocin; D007986:Luteinizing Hormone